Five9 Inc (FIVN) is Trading Higher on Unusual Volume for December 21

Equities Staff  |

Five9 Inc (FIVN) experienced unusually high volume on Dec. 21, as the stock gained 2.1% to a closing price of $7.77. The stock saw 978,604 shares trade hands over the course of the day on 3,219 trades. Given that the stock’s average daily volume over the last month has been 384,693 shares a day, this represents a pretty substantial spike over the norm.

Five9 Inc has a P/B ratio of 14.66. The stock has traded between $7.83 and $3.48 over the last 52-weeks, its 50-day SMA is now $5.62, and its 200-day SMA $5.12.

Five9 Inc provides cloud software for contact centers. The Company is engaged in providing research, development and client support services for contact centers.

Headquartered in San Ramon, DE, Five9 Inc has 680 employees and is currently under the leadership of CEO Michael Burkland.

For a complete fundamental analysis analysis of Five9 Inc, check out’s Stock Valuation Analysis report for FIVN. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Dominic Briggs General Partner Blockwall Management

Matt Bird sits down with Dominic Briggs, General Partner Blockwall Management at the World Economic Forum at Davos 2019

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…